ATLANTA, GA--(Marketwired - November 26, 2013) -
Marc Long, PhD, Senior Director, Technology and Innovation, Stryker Orthobiologics, will provide a keynote address at the second annual Clinical Research in Georgia
Conference. The Conference will be held on December 4th, 2013, at the Academy of Medicine in the heart of midtown Atlanta.
An experienced researcher with extensive management experience in R&D, Long will offer insights into how a global powerhouse like Stryker approaches the acquisition and development of life-changing innovations, with a focus on the intersection of biologics and medical devices.
In his position, Long identifies, evaluates and integrates new disruptive technologies and business opportunities in Sports Medicine orthobiologics and soft tissue healing therapies. He also coordinates relationships and programs with academic centers and clinical entities to stay abreast of clinical needs and conduct translational research.
Long joined Stryker Orthopaedics in 2005 as Research Director. In this position he consolidated the R&D research pipeline and strategy, with a focus on infection, bone subs and soft tissue biological repair. That put him at the ground level of Stryker's new Joint Preservation division as Director of Research and Innovation.
Long began his career at Smith & Nephew Orthopaedics in 1996, starting as a Research Engineer in the Materials & Processing R&D group. The following nine years, he worked on new orthopaedic implants and technologies and disruptive bearing surfaces, leading the creation of an Orthobiologics group to develop and commercialize bone substitute products, autologous biological therapies, and bioactive compounds.
After graduating from Arts et Métiers ParisTech ENSAM in France in 1989 (ENSAM is the French leading engineering school in the fields of mechanics and industrialization) with an Engineering Degree in Mechanical Engineering. After an MSc in Materials Science & Engineering in 1992, he pursued a PhD in Bioengineering at Clemson University.
The theme of the Clinical Research in Georgia Conference is "From Cradle to Rocker," and speakers will spotlight innovations that impact different stages of life, from pediatrics to middle age to senior care. The Conference provides valuable information for those involved with research and raises national awareness of Georgia as a highly desirable site for clinical trials. It is presented by the Metro Atlanta Chamber with the Georgia Department of Economic Development and leading academic institutions.
Information on the conference and registration is available at www.ClinicalResearchGA.org.
About the Metro Atlanta Chamber
The Metro Atlanta Chamber works to attract the best companies and jobs in the hottest industry sectors. Atlanta and Georgia are already powerhouses for the rapidly growing bioscience and health IT industries; the bioscience industry supports more than 94,000 jobs in Georgia and delivers an annual economic impact of $20 billion. The health IT industry in Georgia leads the nation with more than 250 companies and nearly 30,000 jobs. Nine top Atlanta health IT companies report over $4 billion in annual revenue. Learn more at www.MetroAtlantaChamber.com.